WO2019004968A3 - Use of a vegetal formulation containing pomegranate seed oil as an immune system enhancer due to its antioxidant function - Google Patents

Use of a vegetal formulation containing pomegranate seed oil as an immune system enhancer due to its antioxidant function Download PDF

Info

Publication number
WO2019004968A3
WO2019004968A3 PCT/TR2018/050157 TR2018050157W WO2019004968A3 WO 2019004968 A3 WO2019004968 A3 WO 2019004968A3 TR 2018050157 W TR2018050157 W TR 2018050157W WO 2019004968 A3 WO2019004968 A3 WO 2019004968A3
Authority
WO
WIPO (PCT)
Prior art keywords
seed oil
vegetal
pomegranate seed
immune system
antioxidant function
Prior art date
Application number
PCT/TR2018/050157
Other languages
French (fr)
Other versions
WO2019004968A2 (en
WO2019004968A9 (en
Inventor
Mevlüt Büyükhelvacigi̇l
Original Assignee
Helvacizade Gida İlaç Ki̇mya Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helvacizade Gida İlaç Ki̇mya Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ filed Critical Helvacizade Gida İlaç Ki̇mya Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇
Publication of WO2019004968A2 publication Critical patent/WO2019004968A2/en
Publication of WO2019004968A3 publication Critical patent/WO2019004968A3/en
Publication of WO2019004968A9 publication Critical patent/WO2019004968A9/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Organic Chemistry (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention relates to the use of a vegetal formulation in the pharmaceutical industry prepared in capsule form by using pomegranate seed oil rich in essential fatty acids such as punicic acid (Omega 5) as an immune system enhancer due to the formulation's antioxidant function in protection of health which comprises pomegranate seed oil, dl a-tocopherol, dl a-tocopheryl acetate, glycerine, purified water and gelatin that procures the integrity of the content and the capsulated formation.
PCT/TR2018/050157 2017-04-19 2018-04-10 Use of a vegetal formulation containing pomegranate seed oil as an immune system enhancer due to its antioxidant function WO2019004968A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR2017/05828 2017-04-19
TR2017/05828A TR201705828A2 (en) 2017-04-19 2017-04-19 USAGE OF AN IMPROVEMENT OF IMMUNE SYSTEM AS AN ANTIOXIDANT PROPERTIES OF A VEGETABLE FORMULATION CONTAINING Pomegranate Seed Oil

Publications (3)

Publication Number Publication Date
WO2019004968A2 WO2019004968A2 (en) 2019-01-03
WO2019004968A3 true WO2019004968A3 (en) 2019-02-14
WO2019004968A9 WO2019004968A9 (en) 2019-04-11

Family

ID=64743059

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/TR2018/050157 WO2019004968A2 (en) 2017-04-19 2018-04-10 Use of a vegetal formulation containing pomegranate seed oil as an immune system enhancer due to its antioxidant function

Country Status (2)

Country Link
TR (1) TR201705828A2 (en)
WO (1) WO2019004968A2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104189283A (en) * 2014-09-04 2014-12-10 上海浦东高星生物技术研究所 Pomegranate seed oil drop pill
CN105963350A (en) * 2016-03-16 2016-09-28 安徽珠峰生物科技有限公司 A natural vitamin e soft capsule

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104189283A (en) * 2014-09-04 2014-12-10 上海浦东高星生物技术研究所 Pomegranate seed oil drop pill
CN105963350A (en) * 2016-03-16 2016-09-28 安徽珠峰生物科技有限公司 A natural vitamin e soft capsule

Also Published As

Publication number Publication date
WO2019004968A2 (en) 2019-01-03
WO2019004968A9 (en) 2019-04-11
TR201705828A2 (en) 2017-07-21

Similar Documents

Publication Publication Date Title
BR112012026758A2 (en) capsule, method for producing capsules with a core / shell structure, uses of capsules with a core / shell structure, and powdery or liquid preparations, and pharmaceutical composition, cosmetics, crop protection preparation, animal feed, food or nutritional supplement
NZ741022A (en) Flavonoid compositions and methods of use
RU2017129161A (en) LIPID COMPOSITIONS
MX2019013095A (en) Pharmaceutical formulations of statins and omega-3 fatty acids for encapsulation.
AR089441A1 (en) GELATIN / ALGINATE CAPSULES OF DELAYED LIBERATION THAT INCLUDE OMEGA-3 FATTY ACIDS AND METHODS AND USES OF THE SAME, MANUFACTURE METHOD, PHARMACEUTICAL COMPOSITION
BR112012026596A2 (en) A method for preparing pharmaceutical compositions intended for oral administration comprising one or more active ingredients and compositions comprising them.
RU2014119376A (en) NEW COATING SYSTEM
WO2015016822A3 (en) Solid dietary compositions for ruminants and methods of making and using the same
EP2663295B1 (en) Highly concentrated liquid acetaminophen solutions
WO2019004968A3 (en) Use of a vegetal formulation containing pomegranate seed oil as an immune system enhancer due to its antioxidant function
KR20140116482A (en) Organic emulsion comprising dha and epa
PH12017500269A1 (en) Composite formulation for oral administration comprising omega-3 fatty acid esters and statins
WO2019004969A3 (en) Use of a vegetal formulation containing pomegranate seed oil as an assistive agent in reduction of blood lipids known as triglyceride
US9925229B1 (en) Anti-aging composition method
UA117416C2 (en) MEDICINAL IN THE FORM OF SYRUP FOR THE ORAL APPLICATION OF A WIDE SPECTRUM OF ACTION
Madireddy et al. Nutritional interventions for the prevention and treatment of neurological disorders such as anxiety, bipolar disorder, depression, epilepsy, multiple sclerosis, and schizophrenia
AR097148A1 (en) FOOD COMPOSITION FOR RUMINANTS AND METHOD TO PREPARE IT
RU2016112012A (en) LUBRICANT COMPOSITION FOR MOUTH
EA201692398A1 (en) HOMOGENE COMPOSITION FOR ORAL ADMINISTRATION, CONTAINING OMEGA-3 POLYINSATURATED FATTY ACIDS AND RESVERATROL
WO2018226191A3 (en) Use of a herbal formulation containing linseed oil in the treatment of mild gastrointestinal (gastrointestinal system) disorders
WO2018226192A3 (en) Use of a herbal formulation containing linseed oil on those who cannot use fish oil, particularly on vegetarians as a herbal omega 3 (ala) source
EA201890479A1 (en) HYDROPHOBIC GEL BASED ON VITAMIN E WITHOUT SILICONE PRODUCTS FOR LOCAL APPLICATION
JP6602578B2 (en) Oral composition
WO2018222167A3 (en) Use of a herbal formulation containing linseed oil in the treatment of cardiovascular system diseases
JP2015117211A5 (en)

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18823680

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 18823680

Country of ref document: EP

Kind code of ref document: A2